These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7485321)

  • 1. Daily antenatal testing in women with severe preeclampsia.
    Chari RS; Friedman SA; O'Brien JM; Sibai BM
    Am J Obstet Gynecol; 1995 Oct; 173(4):1207-10. PubMed ID: 7485321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial amniotic fluid index in severe preeclampsia: a poor predictor of adverse outcome.
    Schucker JL; Mercer BM; Audibert F; Lewis RL; Friedman SA; Sibai BM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):1018-23. PubMed ID: 8885768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative management in severe pre-eclampsia].
    Romero Arauz JF; Lara González AL; Izquierdo Puente C
    Ginecol Obstet Mex; 2000 Feb; 68():51-4. PubMed ID: 10774104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor.
    Kjos SL; Leung A; Henry OA; Victor MR; Paul RH; Medearis AL
    Am J Obstet Gynecol; 1995 Nov; 173(5):1532-9. PubMed ID: 7503197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.
    Sibai BM; Mercer BM; Schiff E; Friedman SA
    Am J Obstet Gynecol; 1994 Sep; 171(3):818-22. PubMed ID: 8092235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
    Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
    Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expectant versus aggressive management in severe preeclampsia remote from term.
    Sarsam DS; Shamden M; Al Wazan R
    Singapore Med J; 2008 Sep; 49(9):698-703. PubMed ID: 18830544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal outcome with the modified biophysical profile.
    Nageotte MP; Towers CV; Asrat T; Freeman RK
    Am J Obstet Gynecol; 1994 Jun; 170(6):1672-6. PubMed ID: 8203424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal testing among 1001 patients at high risk: the role of ultrasonographic estimate of amniotic fluid volume.
    Magann EF; Chauhan SP; Kinsella MJ; McNamara MF; Whitworth NS; Morrison JC
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 1):1330-6. PubMed ID: 10368467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Umbilical artery Doppler velocimetry and adverse perinatal outcome in severe pre-eclampsia].
    Romero Arauz JF; Ramos León JC; Rivera Velásquez P; Álvarez Jiménez G; Molina Pérez CJ
    Ginecol Obstet Mex; 2008 Aug; 76(8):440-9. PubMed ID: 18798446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amniotic fluid index vs single deepest pocket technique during modified biophysical profile: a randomized clinical trial.
    Chauhan SP; Doherty DD; Magann EF; Cahanding F; Moreno F; Klausen JH
    Am J Obstet Gynecol; 2004 Aug; 191(2):661-7; discussion 667-8. PubMed ID: 15343260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antepartum predictors of fetal distress in postterm pregnancy.
    Bochner CJ; Medearis AL; Davis J; Oakes GK; Hobel CJ; Wade ME
    Am J Obstet Gynecol; 1987 Aug; 157(2):353-8. PubMed ID: 3618684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable decelerations in reactive nonstress tests with decreased amniotic fluid index predict fetal compromise.
    Hoskins IA; Frieden FJ; Young BK
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):1094-8. PubMed ID: 1951521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation.
    Haddad B; Deis S; Goffinet F; Paniel BJ; Cabrol D; Siba BM
    Am J Obstet Gynecol; 2004 Jun; 190(6):1590-5; discussion 1595-7. PubMed ID: 15284743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
    Haddad B; Kayem G; Deis S; Sibai BM
    Am J Obstet Gynecol; 2007 Mar; 196(3):237.e1-5. PubMed ID: 17346535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic values of concurrent nonstress testing, amniotic fluid measurement, and Doppler velocimetry in screening a general high-risk population.
    Devoe LD; Gardner P; Dear C; Castillo RA
    Am J Obstet Gynecol; 1990 Sep; 163(3):1040-7; discussion 1047-8. PubMed ID: 2206056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle cerebral/umbilical artery resistance index ratio as sensitive parameter for fetal well-being and neonatal outcome in patients with preeclampsia: case-control study.
    Ebrashy A; Azmy O; Ibrahim M; Waly M; Edris A
    Croat Med J; 2005 Oct; 46(5):821-5. PubMed ID: 16158478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome.
    Baron C; Morgan MA; Garite TJ
    Am J Obstet Gynecol; 1995 Jul; 173(1):167-74. PubMed ID: 7631675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.